Coadministration has not been studied but based on metabolism and clearance a clinically significant interaction is unlikely. Isoniazid is acetylated in the liver to form acetylisoniazid. The latter is further hydrolysed to isonicotinic acid and acetylhydrazine. Darunavir/cobicistat is unlikely to interfere with this metabolic pathway.